RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
PTC Therapeutics Stock

PTC Therapeutics ROA 2024

PTC Therapeutics ROA

-0.33

Ticker

PTCT

ISIN

US69366J2006

WKN

A1W0MW

In 2024, PTC Therapeutics's return on assets (ROA) was -0.33, a 0.85% increase from the -0.33 ROA in the previous year.

PTC Therapeutics Aktienanalyse

What does PTC Therapeutics do?

PTC Therapeutics Inc. is a biopharmaceutical company based in South Plainfield, New Jersey. The company was founded in 1998 and focuses on the research and development of drugs for the treatment of rare diseases. The company has two main divisions: product research and development, and science and innovation. Its product range includes several drugs for the treatment of rare diseases such as Duchenne muscular dystrophy, spinal muscular atrophy, and cystic fibrosis. One of its key products is Translarna, the first RNA-targeted drug approved for the treatment of Duchenne muscular dystrophy. Another product is Evrysdi, approved for the treatment of spinal muscular atrophy. PTC Therapeutics also has a pipeline of drugs being tested in clinical trials for various rare diseases. The company is committed to promoting innovation and has partnerships with academic institutions and other companies to explore and develop new therapies. Overall, PTC Therapeutics aims to improve the lives of patients with rare diseases through innovative treatments. PTC Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding PTC Therapeutics's Return on Assets (ROA)

PTC Therapeutics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing PTC Therapeutics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider PTC Therapeutics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in PTC Therapeutics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about PTC Therapeutics stock

What is the Return on Assets (ROA) of PTC Therapeutics this year?

The Return on Assets (ROA) of PTC Therapeutics is -0.33 undefined this year.

What was the ROA of PTC Therapeutics compared to the previous year?

The ROA of PTC Therapeutics has increased by 0.85% compared to the previous year.

What consequences do high ROA have for investors of PTC Therapeutics?

A high ROA is advantageous for investors of PTC Therapeutics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in PTC Therapeutics?

A low ROA can be unfavorable for investors of PTC Therapeutics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of PTC Therapeutics affect the company?

An increase in ROA of PTC Therapeutics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of PTC Therapeutics impact the company?

A reduction in the ROA of PTC Therapeutics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of PTC Therapeutics?

Some factors that can influence the ROA of PTC Therapeutics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of PTC Therapeutics important for investors?

The ROA of PTC Therapeutics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can PTC Therapeutics take to improve ROA?

To improve ROA, PTC Therapeutics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does PTC Therapeutics pay?

Over the past 12 months, PTC Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PTC Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of PTC Therapeutics?

The current dividend yield of PTC Therapeutics is .

When does PTC Therapeutics pay dividends?

PTC Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of PTC Therapeutics?

PTC Therapeutics paid dividends every year for the past 0 years.

What is the dividend of PTC Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is PTC Therapeutics located?

PTC Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von PTC Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of PTC Therapeutics from 8/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/6/2024.

When did PTC Therapeutics pay the last dividend?

The last dividend was paid out on 8/6/2024.

What was the dividend of PTC Therapeutics in the year 2023?

In the year 2023, PTC Therapeutics distributed 0 USD as dividends.

In which currency does PTC Therapeutics pay out the dividend?

The dividends of PTC Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von PTC Therapeutics

Our stock analysis for PTC Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PTC Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.